Big Move For Biocept, Inc.

Wed 04 Mar 20 at 05:30 PM
Big Move For Biocept, Inc.

Biocept, Inc. (BIOC:NASDAQ) soared at $0.57, a gain of 38.5%. The stock got featured on our News Catalysts scanner on Mon 10 Feb 20 at 09:19 AM in the 'AGREEMENT' category. From Tue 11 Feb 20, the stock recorded 21.43% Up Days and 13.33% Green Days

The stock spiked on Fri 28 Feb 20 at $0.79 with a volume of 88M+.

About Biocept, Inc. (BIOC:NASDAQ)

Biocept Inc is an early commercial-stage molecular oncology diagnostics company. It develops and commercializes proprietary circulating tumor cell and circulating tumor DNA assays utilizing a standard blood sample.